Alan Fournier's portfolio and holdings - Dec 2023

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 36 stocks with a net worth of over US$ 445.4 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Add Superstar Alert
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Agenus Inc Pennant Investors Lp 5.96 469,600 0.11% NEW 2.8 M
Agios Pharmaceuticals Inc Pennant Investors Lp 40.00 15,100 0.03% NEW 604 K
Allogene Therapeutics Inc Pennant Investors Lp 1.50 128,400 0.08% NEW 192.6 K
Altimmune Inc Pennant Investors Lp 4.08 109,800 0.15% NEW 448.0 K
Amazon.com Inc. Pennant Investors Lp 231.44 348,000 0.00% 0.00 80.5 M
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 14.94 13,100 0.05% NEW 195.7 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 14.86 170,900 0.15% NEW 2.5 M
BioXcel Therapeutics Inc Pennant Investors Lp 1.81 83,900 0.23% NEW 151.9 K
Coherus Biosciences Inc Pennant Investors Lp 1.04 168,100 0.15% NEW 174.8 K
Compass Therapeutics Inc Pennant Investors Lp 3.18 199,000 0.14% NEW 632.8 K
Enanta Pharmaceuticals Inc Pennant Investors Lp 7.40 35,100 0.17% NEW 259.7 K
Erasca Inc Pennant Investors Lp 1.74 166,200 0.11% NEW 289.2 K
89bio Inc Pennant Investors Lp 9.59 44,500 0.05% NEW 426.8 K
Fate Therapeutics Inc Pennant Investors Lp 1.24 146,100 0.13% NEW 181.2 K
FibroGen Inc Pennant Investors Lp 7.45 768,400 0.77% NEW 5.7 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 193.18 375,000 0.00% 0.00 72.4 M
IGM Biosciences Inc Pennant Investors Lp 1.27 64,900 0.11% NEW 82.4 K
Kalaris Therapeutics Inc. Pennant Investors Lp 2.76 215,700 0.19% NEW 595.3 K
Seres Therapeutics Inc Pennant Investors Lp 14.53 292,300 0.19% NEW 4.2 M
Macrogenics Inc Pennant Investors Lp 1.71 43,800 0.07% NEW 74.9 K
Microsoft Corporation Pennant Investors Lp 513.71 129,000 0.00% 0.00 66.3 M
Micron Technology Inc. Pennant Investors Lp 111.26 306,000 0.03% 0.00 34.0 M
Nurix Therapeutics Inc Pennant Investors Lp 11.52 56,800 0.09% NEW 654.3 K
Novavax, Inc. Pennant Investors Lp 7.47 60,300 0.04% NEW 450.4 K
ODP Corporation (The) Pennant Investors Lp 18.58 400,000 1.10% 0.02 7.4 M
uniQure N.V. Pennant Investors Lp 15.11 48,500 0.10% NEW 732.8 K
Replimune Group Inc Pennant Investors Lp 3.15 30,500 0.05% NEW 96.1 K
Relay Therapeutics Inc Pennant Investors Lp 3.74 42,400 0.03% NEW 158.6 K
Sage Therapeutics Inc Pennant Investors Lp 8.80 17,500 0.03% NEW 154 K
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 29.67 2,153,209 0.79% NEW 63.9 M
Travere Therapeutics Inc Pennant Investors Lp 15.32 55,800 0.07% NEW 854.9 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.47 32,400 0.05% NEW 47.6 K
Zymeworks BC Inc Pennant Investors Lp 13.33 38,700 0.05% NEW 515.9 K
Antero Resources Corp Pennant Investors Lp 32.53 913,000 0.29% -0.01 29.7 M
Arcus Biosciences Inc Pennant Investors Lp 10.23 23,700 0.03% NEW 242.5 K
Transdigm Group Incorporated Pennant Investors Lp 1607.45 42,000 0.08% 0.00 67.5 M
View All The Superstar Shareholder Portfolios